154 related articles for article (PubMed ID: 33217696)
1. Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
Molazadeh N; Mohebi F; Altafi D; Sahraian MA
Mult Scler Relat Disord; 2021 Jan; 47():102605. PubMed ID: 33217696
[TBL] [Abstract][Full Text] [Related]
2. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
3. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
6. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
[TBL] [Abstract][Full Text] [Related]
7. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
8. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
9. Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
Eskandarieh S; Sahraiain MA; Molazadeh N; Moghadasi AN
Mult Scler Relat Disord; 2019 Nov; 36():101377. PubMed ID: 31473489
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
12. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Ashtari F; Baghbanian SM; Razazian N; Moghadasi AN; Bayati A; Azimi AR; Beladimoghadam N; Harirchian MH; Poursadeghfard M; Navardi S; Shirkoohi R; Heidari H; Ghaffari M; Eskandarieh S
BMC Neurol; 2022 Mar; 22(1):76. PubMed ID: 35248009
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
16. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
17. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
Barzegar M; Vaheb S; Mirmosayyeb O; Ashtari F; Afshari-Safavi A; Adibi I; Shaygannejad A; Mazaheri S; Rahimi M; Shaygannejad V
Mult Scler Relat Disord; 2024 Apr; 84():105479. PubMed ID: 38359695
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).
Razazian N; Eskandarieh S; Siabani S; Afshari D; Sahraian MA; Khezri O; Rezaei M; Fakhri N
Mult Scler Relat Disord; 2022 Jan; 57():103441. PubMed ID: 34896874
[TBL] [Abstract][Full Text] [Related]
20. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
Pakdel M; Karin Hedström A; Bidkhori M; Hadei M; Kazemi Moghaddam V; Sarmadi M; Zohdi S; Marufi N
Acta Neurol Scand; 2019 Nov; 140(5):328-335. PubMed ID: 31291697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]